Ligand Partner Viking Therapeutics Announces Closing of Initial Public Offering, 3M Shares @ $8/Shr
May 05, 2015 at 08:13 AM EDT
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Viking Therapeutics, Inc. (NASDAQ: VKTX) announced that it had closed its ...